Jupiter Life Line Hospitals Ltd. Share Price

Overview

Jupiter Life Line Hospitals Ltd. share price is currently ₹241.19, down by - ₹1.75 (0.72%) from its previous closing price of ₹242.94. The share price has declined -11.18% over the past month and declined -19.43% over the past year. The stock's 52-week low and high are ₹231.43 and ₹334.13, respectively. Jupiter Life Line Hospitals Ltd. has a market capitalisation of ₹ 8,100.00 Cr. The share price was last updated on 23 Oct 2026, 03:29 PM IST.

Jupiter Life Line Hospitals Ltd.
Jupiter Life Line Hospitals Ltd.
JLHL
 ₹0.00
- ₹1.75
0.72%
Healthcare
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:29:58 pm IST

Market Data

Open Price

 ₹242.92

Prev. Close

 ₹242.94
 ₹231.43

Day Low

 ₹252.11

Day High

 ₹231.43

52 Week Low

 ₹334.13

52 Week High

HealthcareHospital & Healthcare Services
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

42.39

Sector PE

42.08

PB Ratio

1.02

Sector PB

5.48

EPS

5.69

Dividend Yield

0.08

Today's Volume

303.158 K

5 Day Avg. Volume

151.274 K

PEG Ratio

100.93

Market Cap.

₹ 8,100.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
Stock Split2:10
24-Jul-202624-Jul-2026
DividendsInterim Dividend of 10% at ₹1/Share
22-May-202622-May-2026
DividendsFinal Dividend of 10% at ₹1/Share
04-Jul-202504-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
SBI Multicap Fund - Regular Plan - Growth2.00 Cr
1.94 Cr
(3.23%)
SBI Healthcare Opportunities Fund - Regular Plan - IDCW50.00 Lac
50.00 Lac
no change
HDFC Multi Cap Fund - Regular Plan - Growth42.56 Lac
42.56 Lac
no change
HDFC Small Cap Fund - Regular Plan - Growth42.48 Lac
42.48 Lac
no change
HDFC Pharma and Healthcare Fund - Regular Plan - Growth21.75 Lac
23.24 Lac
(6.87%)

About Jupiter Life Line Hospitals Ltd. 👋

Jupiter Life Line Hospitals Limited is an India-based holding company. The Company is a multi-specialty tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and western India. The Company has a total bed capacity of approximately 1,061 hospital beds across three hospitals. The Company operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. It is equipped with over 30 specialty treatments, such as bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, gastroenterology, infectious diseases, internal medicine, mental health, nephrology, neurology, neurosurgery, and nutrition and dietetics. The Company also owns Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company's subsidiaries include Jupiter Hospital Projects Private Limited and Medulla Healthcare Private Limited.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Ankush

Ankush

16 Jul • 10:24 AM · SEBI-Registered Analyst

HDFCAMC

HDFC Asset Management Company (AMC) bought shares worth Rs 139 crore in Jupiter Life Line Hospitals while reducing its exposure to TCI Express by selling a 1.3 percent stake through open market transactions on July 15. According to bulk deal data, HDFC Mutual Fund acquired 9.37 lakh shares, equivalent to a 1.42 percent stake, in the multi-specialty hospital chain Jupiter Life Line Hospitals for Rs 139 crore at an average price of Rs 1,483.5 per share. The shares were sold by two non-institutional investors. Mitul Nitin Thakker sold 6 lakh shares worth Rs 89.01 crore, while Arvind Rao Kamini offloaded 3.37 lakh shares valued at Rs 49.99 crore. As of the March 2026 shareholding pattern, Thakker held a 1.22 percent stake (7.99 lakh shares) in the company, while Kamini owned 1.63 percent (10.66 lakh shares). In a separate bulk deal, Nippon India Mutual Fund purchased 5 lakh shares, representing a 1.3 percent stake, in logistics firm TCI Express from HDFC Mutual Fund for Rs 28.1 crore. The transaction was executed at Rs 562 per share. According to the March 2026 shareholding data, HDFC AMC, through its Large and Mid Cap Fund, held a 4.04 percent stake in TCI Express, while Nippon Life India Trustee, via the Nippon India Multi Cap Fund, owned 3.02 percent. Shares of Jupiter Life Line Hospitals ended 1.1 percent higher at Rs 1,499.8 on the NSE, marking their third consecutive session of gains amid strong trading volumes. The stock has remained above all key moving averages since June 2026, reflecting sustained bullish momentum.

See More
Pradeep Carpenter

Pradeep Carpenter

15 Jul • 10:27 PM · SEBI-Registered Analyst

Healthcare Stock Attracts Fresh Mutual Fund Investment

HDFC Mutual Fund made a significant bulk deal by purchasing a 1.42% stake in Jupiter Life Line Hospitals worth around ₹139 crore at ₹1,483.50 per share. The investment reflects continued institutional interest in the healthcare sector and may provide positive sentiment for the stock in the near term. In a separate transaction, HDFC Mutual Fund sold its 1.3% stake in TCI Express for approximately ₹28 crore at ₹562 per share. However, the shares were acquired by Nippon India Mutual Fund, indicating that the stake has shifted between institutional investors rather than witnessing an institutional exit. Overall, the bulk deals are sentimentally positive for Jupiter Life Line Hospitals due to fresh institutional buying, while the impact on TCI Express appears largely neutral as institutional ownership remains intact. Investors should continue to track earnings performance and business fundamentals for further direction.

JLHL
TCIEXP

See More
Chahat Aggrawal

Chahat Aggrawal

17 May • 5:49 PM · SEBI-Registered Analyst

Jupiter Life Line Hospitals Publishes Q4 & FY26 Results Notice

🏥

JLHL
has filed a newspaper publication intimation for its Q4 and FY26 financial results, reporting Q4 consolidated revenue of ₹3,878.38 million and net profit of ₹502.67 million, while also declaring an interim dividend of ₹1 per share.

See More
Tejaswi

Tejaswi

15 May • 10:57 AM · SEBI-Registered Analyst

Jupiter Life Line: Big Bets, Big Stakes

JLHL
Jupiter Life Line Hospitals is moving from a three-hospital regional chain to a much larger western India platform. The company’s plan is to double bed capacity to about 2,500 beds by CY29, up from around 1,048 beds as of March 2026, through new hospitals in Pune, Mira-Bhayandar and Dombivli. That makes the stock a clear growth story, but also a capex-heavy one. The core numbers are strong. In Q3FY25, revenue rose 17.6% year on year to Rs 3,206 million, EBITDA increased 21.2% to Rs 750 million, and adjusted PAT grew 19.8% to Rs 525 million. EBITDA margin improved to 23.4% from 22.7%, while blended occupancy stood at 65.7% and ARPOB reached Rs 61,750. These are healthy operating trends, not just headline expansion. The expansion plan is large. Jupiter had already added 78 beds at Indore on 1 Jan’25 for a capex of Rs 250 million, and the hospital then had 309 beds. It also planned a 200–220 bed first phase at Dombivli by Q1FY27, two new hospitals in Pune and Mira-Bhayandar, and about Rs 9 billion of capex for the next two hospitals, with a wider Rs 14–16 billion plan over CY27–29. For shareholders, this is attractive if execution stays strong. More beds, higher occupancy and better ARPOB can lift revenue and margins because hospitals become more efficient at scale. But the risk is equally real: new hospitals can lose money in the early phase, cash balances may fall, and debt may rise before the new capacity starts paying back. ICRA also noted that occupancy had softened to 61.9% in 9MFY26 from 67.5% a year earlier, even though ARPOB improved to Rs 66,800. So the stock looks valuable, but not cheap. Jupiter is a good shareholder story if investors are comfortable with execution risk, high capital spending and a few years of waiting before the full earnings benefit arrives.

See More
Power Of Finance (SEBI RA)

Power Of Finance (SEBI RA)

1 Apr • 10:57 AM · SEBI-Registered Analyst

Jupiter Infomedia: Divyeshkumar Mansukhlal Savaliya Acquires 6.18% Stake

JLHL
Jupiter Infomedia witnessed a significant stake acquisition by Divyeshkumar Mansukhlal Savaliya, who purchased 619582 shares representing 6.18% through open market transaction. The acquisition was properly disclosed under SEBI regulations, with the investor entering as a new non-promoter shareholder.

See More
Shrikant Pandey

Shrikant Pandey

27 Mar • 1:31 PM · SEBI-Registered Analyst

JLHL

Jupiter Life Line Wins BKC Land for 400-Bed Hospital Project • 🏥 Major Expansion: Secures ~10,026 sq.m land in Bandra-Kurla Complex (BKC) • 📜 Long-Term Lease: Land allotted by MMRDA for 80 years • 💰 Investment: Lease premium of ₹354 Cr • 🛏️ Capacity Addition: Plans to build ~400-bed hospital • 📍 Prime Location: Entry into high-value Mumbai healthcare hub • 📈 Growth Visibility: Strengthens footprint in premium healthcare segment 🟢 Impact: Positive Boosts capacity expansion & long-term revenue potential in a prime location

See More

News & Events

Frequently Asked Questions

What is the share price of Jupiter Life Line Hospitals Ltd.?

What is the market cap of Jupiter Life Line Hospitals Ltd.?

Should I buy Jupiter Life Line Hospitals Ltd. stock now?

What is the 52 week high and low of Jupiter Life Line Hospitals Ltd.?

Is the Jupiter Life Line Hospitals Ltd. stock good to buy?

Is Jupiter Life Line Hospitals Ltd. a good buy for the long term?

Is Jupiter Life Line Hospitals Ltd. overvalued or undervalued?

What is the PE and PB ratio of Jupiter Life Line Hospitals Ltd.?

Start Now